| abstract |
The invention relates to a depigmenting composition capable of acting against the signs of skin darkening and, in particular, acting at the dermis-epidermis interface, which enables, when combined, to promote skin lightening. more particularly, such a depigmenting composition comprises a combination of at least one tranexamic acid and an alpha arbutin encapsulated in a biocompatible nanoparticle without causing undesirable effects such as genotoxicity or comedogenicity, typical adverse reactions of depigmenting or skin lightening compositions. |